Potassium Chloride in Sodium Chloride NDC 63323-686

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-686Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0686Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-686-10	63323068610	10 BAG in 1 CARTON (63323-686-10) / 1000 mL in 1 BAG (63323-686-01)Marketed from Jun 2, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Chloride in Sodium Chloride
Generic name (nonproprietary): sodium chloride and potassium chloride
Active ingredients: Sodium chloride — 900 mg/100mLPotassium chloride — 150 mg/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212347
Marketing start: Jun 2, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 63323-686_23c084c3-6c81-4691-9e86-0c2a17df7076SPL ID 23c084c3-6c81-4691-9e86-0c2a17df7076SPL set ID c2467d57-cd2d-4409-bcc0-50128bd01bbaRxCUI 237367, 403890, 637551UNII 451W47IQ8X, 660YQ98I10
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323068610 followed by a unit qualifier and the quantity

Package 63323-0686-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 30, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212347

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212347
Product	Strength	Form · route	Labeler	Product NDC
Potassium Chloride in Sodium Chloridesodium chloride and potassium chloride	Sodium chloride 450 mg/100mL; Potassium chloride 150 mg/100mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-683
Potassium Chloride in Sodium Chloridesodium chloride and potassium chloride	Sodium chloride 900 mg/100mL; Potassium chloride 300 mg/100mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-688